Atlas Trials

Effect of CT1812 Treatment on Brain Synaptic Density

Clinical trial NCT03493282 · COMPLETED

Trial details

NCT number
NCT03493282
Sponsor
Cognition Therapeutics
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2018-03-28
Primary completion
2020-10-16
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.